Is retention on ART underestimated due to patient transfers

Slides:



Advertisements
Similar presentations
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Advertisements

REASONS FOR LONG-TERM LOSS TO FOLLOW UP OF ADULT ART PATIENTS IN SOUTH AFRICA: A PROSPECTIVE, QUALITATIVE STUDY METHODS RESULTS POLICY RECOMMENDATIONS.
Using longitudinal, population-based HIV surveillance to measure the real-world impacts of ART scale-up in KwaZulu- Natal, South Africa Frank Tanser Presentation.
Impact of IMPACT Patients’ Demographic Characteristics and Outcomes An analysis of FHI Initial ART Sites Philippe Chiliade, MD, MHA.
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Estimating the number of Kentuckians living with HIV disease with unmet needs for HIV-related primary care in calendar year 2010  Reducing new HIV infections.
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Linked Data Products Vital Statistics Death/PDD Presenter: Jan Morgan.
Cascade The Continuum of HIV Care Florida, 2013 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2013, as of 06/30/2014.
AIDS Turning the Tide Together IAS Satellite: Where the Tide Will Turn: How is Community Level Participation Most Effective in Turning the Tide?
Costs and Outcomes of AIDS Treatment Delivery Models Sydney Rosen ab, Lawrence Long b, Ian Sanne bc a Center for International Health and Development,
Stable Outcomes and Costs in South African Patients’ Second Year on Antiretroviral Treatment Lawrence Long, Health Economics Research Office, Wits Health.
Effects of patient tracing on estimates of lost to follow-up, mortality and retention in antiretroviral therapy programs in low-middle income countries:
Decentralization of HIV care and treatment services in Central Province, Kenya: Adult patient characteristics and outcomes Presenting author: William Reidy,
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Evaluating Cost Gavin Steel, Jude Nwokike, Mohan P. Joshi & Mupela Ntengu Development and Implementation of a Multi-Method Medication Adherence Assessment.
Surveillance to measure impact of ART Theresa Diaz, MD MPH CDC Global AIDS Program.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University July 17, 2011 The first step is admitting you have a problem.
Tracking of Inter-Facility Patient Transfers and Retention on Antiretroviral Treatment in Namibia Presenter Naita Nashilongo Ministry of Health and Social.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
eHARS to CAREWare Pilot Project Update and Training
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Life expectancy of patients treated with ART in the UK: UK CHIC Study Margaret May University of Bristol, Department of Social Medicine, Bristol.
SSuN: MSM prevalence monitoring and HIV Testing in STD Clinics Kristen Mahle & Lori Newman SSuN Call #3 Oct 30, 2008.
Factors Associated with Survival in HIV-Infected African Patients on Antiretroviral Therapy: The Impact of a Sampling-Based Approach to Address Losses.
Good Three-year Outcomes of Antiretroviral Therapy at Multiple NGO- assisted facilities in Four Provinces in South Africa Geoffrey Fatti, Ashraf Grimwood.
Retention in Care among HIV-infected Patients Receiving Antiretroviral Therapy in Africa: Estimation via a Sampling-based Approach Elvin Geng 1, David.
The Continuum of HIV Care Florida, 2014 The Continuum of HIV Care Florida, 2014 Lorene Maddox, MPH Karalee Poschman, MPH Living data through 2014, as of.
Outcomes of Antiretroviral Treatment Programs in Rural Lesotho: Health Centers and Hospitals Compared Niklaus Labhardt, Motlalepula Sello, Mamokone A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Attrition between TB / HIV testing and linkage to care in South Africa’s correctional facilities. 01 December 2015 Vincent Zishiri, Salome Charalambous,
Successfully enrolled in HIV Care but not linked to timely Treatment: Poor retention and Monitoring of Pre-ART patients who are not yet eligible for ART.
Retention in an antiretroviral program in the Democratic Republic of Congo Kalenga Lucien Koole Olivier Menten Joris Kiumbu Modeste Robin Ryder Mukumbi.
Discontinuation from community-based antiretroviral adherence clubs in Gugulethu, Cape Town, South Africa Andile Nofemela, Cathy Kalombo, Catherine Orrell,
Beyond Counting – Using HIV Surveillance Data to Monitor Linkage to Care Following Release from Corrections Liza Solomon DrPH, MHS 9 th Academic and Health.
Boston University Slideshow Title Goes Here District Prevalence of Unsuppressed HIV in South African Women: Monitoring Programme Performance and Progress.
Boston University Slideshow Title Goes Here Eliminating CD4 thresholds in South Africa will not lead to large increases in persons receiving ART without.
Priscilla Tsondai, Lynne Wilkinson, Anna Grimsrud, Angelina Trivino,
Dorina Onoya 1, Cornelius Nattey 1, Eric Budgell 1, Liudmyla van den Berg 2, Denise Evans 1, Mhairi Maskew 1, Kamban Hirasen 1, Lawrence Long 1, Matthew.
New WHO Guidelines on Person centred monitoring
HIV Care Continuum Ryan White Program - Miami-Dade County
PRESENTED AT THE 9TH IAS CONFERENCE ON HIV SCIENCE - PARIS, FRANCE
Earlier treatment and lower mortality in infants Initiating ART at
Continuum of Surveillance Updates from Epidemiological Services New Jersey Department of Health Division of HIV, STD and TB Services (DHSTS) Annual.
Participants 18year old+
NYSDOH AIDS Institute Quality of Care Program eHIVQUAL
David Culliford, Lynn Josephs, Matthew Johnson, Mike Thomas
HIV Care Continuum in Manhattan
Cross-sectional assessment of patient outcomes using a systematic file review process: Results from 12,987 patient files Ambereen Jaffer, Gesine Meyer-Rath,
Predictors of antiretroviral treatment associated tuberculosis in Ethiopia: a nested case control study Nebiyu Mesfin, MD.
Better Retention Rates Observed in Patients on Lopinavir than Atazanavir in Uganda
Utilizing research as an opportunity to strengthen
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
HIV Diagnosis and the Cascade of Care in Ontario
Juan Gonzalez Perez AIDS Healthcare Foundation
The Cost of Differentiated Service Delivery: A Systematic Review
Dr. Velephi Okello, Principal Investigator, MaxART Trial
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Community patient tracking by Lay Community Health Workers (CHWs) is an effective strategy towards the 2nd & 3rd 90 Morapedi Boitumelo M.
Knowing your epidemic and knowing your response – maximising routinely collected data to measure and monitor HIV epidemics in sub-Saharan Africa Monitoring.
Geomapping to Enhance Equitable Access
Effect of POC CD4 testing at HIV diagnosis on attrition prior to ART initiation among youth in Khayelitsha, South Africa Pre-treatment losses to care remains.
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,
Poster WP41; Contact: David A. Katz,
M Javanbakht, S Guerry, LV Smith, P Kerndt
Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD
Stakeholder engagement and research utilization: Insights from Namibia
Treatment Outcome among patients on ART in Southern Tanzania: Does Time of ART initiation Matter?
Public Health Implications
Presentation transcript:

Is retention on ART underestimated due to patient transfers Is retention on ART underestimated due to patient transfers? Estimating system-wide retention using a national labs database in South Africa Matthew Fox1,2, Jacob Bor1,2, Bill MacLeod1,2, Mhairi Maskew2, Alana Brennan1,2, Wendy Stevens3, Sergio Carmona3 1 Department of Global Health, Boston University School of Public Health, USA, 2 Health Economics and Epidemiology Research Office, University of Witwatersrand, South Africa, 3 National Health Laboratory Service, South Africa and Department of Molecular Medicine and Haematology, University of the Witwatersrand Funded by NIAID R01 AI115979

Background Systematic reviews have shown high rates of attrition in patients receiving antiretroviral therapy 36 months retention averages 65%–70% (Fox JAIDS 2015) Attrition includes both death and loss to follow up Clinic perspective is limited: Some patients who request transfer don’t appear at a new clinic Some lost patients return but are counted as new patients (cycling) Some patients lost re-enter care at another clinic (silent transfer) Migration, transfers, silent transfers and cycling may lead to under-estimation of retention in care

Objective To use a new national HIV patient cohort in South Africa created from South Africa’s national laboratory database (National NHLS HIV Cohort), that can identify movement between clinics to assess system-wide retention in care within the public sector We compared system-wide retention to retention at the initiating clinic to explore the impact of transfer to new sites We assessed demographic predictors of system-wide retention in care

Methods The National Health Laboratory Services (NHLS) National HIV cohort NHLS is the main provider of laboratory services for the public-sector program in South Africa Cohort created using all routine CD4/Viral Loads done since 2004 A validated unique patient identifier Exact match on first, last name, DOB, sex, facility Identify candidate matches for probabilistic record linkage Score candidate matches based on similarity (Fellegi-Sunter, 1969) Use graph-based approaches to guide decisions about whether a pair are a match 90% Sensitivity, 90% Positive Predictive Value compared to manually-matched gold standard We have limited information to match on and we have too many matches to score them all Jaro Winkler is a string based comparison for first and last name – those with a weighted average of the two below 0.9 are screened out We also use this again in the Fellegi sunter to weight the scores Fellegi Sunter is a score that can be pos or neg and gives liklelihoods based on rareness of observations Can’t compare all possible links so we limit with the candidate matches Score all cases with the first/last inversion etc Score all in the nickname file – created by looking for statistically rare last names and DOB within a clinic which could only be twins, then had RAs code if they were correct Jaro Winkler done for all case with DOB within 10 years Fellegi-Sunter takes into account how common a variables is sim_scoreij = (first_sim, last_sim, DOB_sim, sex_sim, prov_sim, fac_sim) Clusters are defined setting threshold = t_low Clusters with diameter <=2 placed in final dataset For clusters with diameter >2, threshold is raised, eliminating some potential matches, and network is constructed again. Repeated until all clusters either have diameter <=2 or have all links with tot_sim scores > t_high.

Methods Included all patients starting ART in 2004/2005 with any follow up By guidelines, first viral load was collected at ART initiation Assessed retention as time to a patient's most recent lab result (CD4/VL) Followed patients through March 2015 “Still in care” if their last lab occurred April 2013 - March 2015 Assessed two retention concepts: (a) system-wide retention including all labs regardless of facility (b) retention at initiating clinic, ignoring labs at other facilities Both definitions reflect attrition from death and loss to follow up

Results NHLS National HIV Cohort 9.2 million people have ever sought care for HIV About 40% are single CD4 counts Many who test positive never return to care Likely under-matching 4.2 million ever initiated ART (and VL monitored) 3.1 million currently on ART and VL-monitored

Population Characteristics at first CD4 count Results Population Characteristics at first CD4 count Sex Female 64%       Age <30 35%       30-39.9 39%     ≥40 27%     CD4 <100     36%     100-199 30%       200-349 17%       ≥350 Patients initiating ART in 2004 and 2005 N = 66,865 9-year retention …at initiating clinic: 16.7% (95% CI: 15.8 - 17.7) …system-wide: 54.5% (95%CI: 53.5 – 55.4)

Retention: system-wide vs. clinic perspective System-wide retention % observed at a later date Clinic retention Retained w/in national program Retained at initiating clinic Years since ART initiation 1 year 5 year 9 year System-wide 0.90  (0.89-0.90) 0.72  (0.72-0.72) 0.54 (0.53-0.55) Clinic retention  0.79 (0.79-0.80) 0.37 (0.36-0.37) 0.17 (0.16-0.18)

System-wide retention, by first CD4 count >=500 <50 % observed at a later date <50 50-99 100-199 200-350 350-499 >=500 Years since ART initiation

System-wide retention, by age at first CD4 <25 years % observed at a later date >50 years <25 25-30 30-40 40-50 >50 Years since ART initiation

System-wide retention by sex Female Male % observed at a later date Female Male Years since ART initiation

Adjusted predictors of attrition* Factor Clinic attrition HR (95% CI) System-wide attrition CD4 <50 1.14 (1.08 - 1.19) 1.25 (1.16 - 1.34) 50-99 1.08 (1.03 - 1.13) 1.14 (1.07 - 1.23) 100-199 1.05 (1.01 - 1.10) 1.06 (0.99 - 1.13) 200-349 1.11 (1.04 - 1.19) 350-499 0.98 (0.93 - 1.04) 1.02 (0.94 - 1.11) >=500 Reference Age <25 0.86 (0.84 - 0.89) 0.78 (0.74 - 0.82) 25-29.9 1.03 (1.00 - 1.06) 1.03 (0.98 - 1.07) 30-39.9 40-49.9 1.01 (0.98 - 1.04) 1.07 (1.03 - 1.11) >=50 1.05 (1.00 - 1.09) 1.27 (1.20 - 1.34) Sex Female 0.95 (0.93 - 0.97) 0.84 (0.82 - 0.87) Male *Also adjusted for province

Conclusions Strengths: Limitations: Size, national scope, ability to see movement between clinics Limitations: Limited data on predictors, over/under matching, no mortality data, doesn’t include patients who never return Patient migration and transfer are common throughout South Africa NHLS National Patient Cohort allows passive tracking of patients regardless of where they seek care Overall retention in care is underestimated using only the clinic wide perspective

Thank you and Acknowledgments Patients, care providers, and NHLS staff Sue Candy (NHLS CDW) Research colleagues at BUSPH, NHLS and HE2RO National Department of Health Funders NIH (NIAID) PEPFAR USAID